Author:
Rhamnolipid Structure‐Function R.o.,Infections Exopolysacharide B.o.P.a.a.T.T.i.C.F.L.
Reference98 articles.
1. Jeffrey BL, Carolyn LC, Gerald BP. Lung infections associated with cystic fibrosis. Clinical Microbiology Reviews. 2002;15:194–222. DOI: 10.1128/CMR.15.2.194–222.2002.
2. Hoiby N. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BioMed Central Medicine. 2011;9:1–7. DOI: 10.1186/1741‐7015‐9‐32
3. Filkins LM, O'Toole GA. Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLoS Pathogens. 2015;11:e1005258. DOI: 10.1371/journal.ppat.1005258
4. Laura MF, Jyoti A G, Daniel GO, Emily LD, Lee RL, Sabin B, O'Toole GA. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa drives S. aureus towards fermentative metabolism and reduced viability in a cystic fibrosis model. Journal of Bacteriology. 2015;197:2252–2264. DOI: 10.1128/JB.00059‐15
5. Cox MJ, Allgaier M, Taylor B, Marshall SB, Yvonne JH, Rebecca AD, Ulas K, Gary LA, Ronald B, Kei EF, Brain W, Diem T, Jonathan K, Susan VL. Airway microbiota and pathogen abundance in age‐stratified cystic fibrosis patients. PLoS One. 2010;5:e11044. DOI: 10.1371/journal.pone.00111044